Fischer JE,Ramser M,Fanconi S．Use of antibiotics intens-ive care and potential savings [J]．Intensive Care Med,2000,26(6)：959-966.
[2]
Brunlhorst F M,AI-Nawas B,Krunmmenauer F,et al.Procalcitonin,C reactive protein and APACHE Ⅱ score for risk evaluation in patients with severe pneumonia [J].Clin Microbiol Infect,2002,8(2):93-100.
[3]
Bouadma L,Luyt CE,Tubach F,et al.Use of procalcitonin to reduce patients’exposure to antibioties in intensive care units(PRORATA trial):a multicentre randomised controlled trial [J].Lancet,2010,375:463-474.
[4]
Medun GU.Diagnosis of ventilator-associated pneumonia [J].Infect Dis Clin North Am,2003,7(2):295-329.
[5]
Schuetz P, Batschw Aroff M, Dusemund F, et al. Effetiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study surrey [J]. Eur J Clin Microbiol Infect Dis, 2010,29(3):269-277.
[6]
Casado Flores J,Blanco Quiros A.Procalcitionin,a new marker for bacterial infection [J].An Esp Pediatr,2001,54:69-73.
[7]
Christ M,Stolz D,Bingisser R,et al．Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia：a randomized trial [J]．Am J Respir Crit Care Med,2006,174(1)：l4-93．
Assicot M,Gendrel D,CarsinH,et al.High serum procalcitonin concentrations in patients with sepsis and infection [J].Lancet,1993,341(8844):515-518.
[10]
Miedema KG,de Bont ES,Elferink RF,et al.The diagnostic value of CRP,IL-8,PCT,and TREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia [J].Support Care Cancer,2011,19(10):1593-1600.
[11]
Assumma M,Signore F,Pacifico L,et al.Serum Procalcitonin concentrations in term delivering mothers and their healthy offspring:a longitudinal study [J].Clin Chem,2000,183：1583-1587.
[12]
Maniaci V,Dauber A,Weiss S,et al．Procalcitonin in young febrile infants for the detection of serious bacterial infections [J]．Pediatrics,2008,122(4)：701-710．
[13]
Lacour AG,Zamora SA,Gervaix A．A score identifying serious bacterial infections in children with fever without source [J]．Pediatr Infect Dis,2008,27(7)：654-656．
[14]
Schuetz P,Christ-Crain M,Thomann R, et al. Effect of procalcitonin based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial [J]. JAMA,2009,302(10):1059-1066.
[15]
Nobre V,Harbarth S,Graf JD,et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial [J]. Am J Respir Crit Care Med,2008,177(5):498-505.
[16]
Albrich wc,Monnet DL,Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes[J]. Emerg Infect Dis,2004,10(3):514-517.
